Cargando…

Specific antibody response of 14 patients with common variable immunodeficiency to 3 BNT162b2 messenger RNA coronavirus disease 2019 vaccinations

Detalles Bibliográficos
Autores principales: Abo-Helo, Nizar, Muhammad, Emad, Ghaben-Amara, Sondus, Cohen, Shai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983475/
https://www.ncbi.nlm.nih.gov/pubmed/35398265
http://dx.doi.org/10.1016/j.anai.2022.03.035
_version_ 1784681983391039488
author Abo-Helo, Nizar
Muhammad, Emad
Ghaben-Amara, Sondus
Cohen, Shai
author_facet Abo-Helo, Nizar
Muhammad, Emad
Ghaben-Amara, Sondus
Cohen, Shai
author_sort Abo-Helo, Nizar
collection PubMed
description
format Online
Article
Text
id pubmed-8983475
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-89834752022-04-06 Specific antibody response of 14 patients with common variable immunodeficiency to 3 BNT162b2 messenger RNA coronavirus disease 2019 vaccinations Abo-Helo, Nizar Muhammad, Emad Ghaben-Amara, Sondus Cohen, Shai Ann Allergy Asthma Immunol Letters American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. 2022-07 2022-04-06 /pmc/articles/PMC8983475/ /pubmed/35398265 http://dx.doi.org/10.1016/j.anai.2022.03.035 Text en © 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letters
Abo-Helo, Nizar
Muhammad, Emad
Ghaben-Amara, Sondus
Cohen, Shai
Specific antibody response of 14 patients with common variable immunodeficiency to 3 BNT162b2 messenger RNA coronavirus disease 2019 vaccinations
title Specific antibody response of 14 patients with common variable immunodeficiency to 3 BNT162b2 messenger RNA coronavirus disease 2019 vaccinations
title_full Specific antibody response of 14 patients with common variable immunodeficiency to 3 BNT162b2 messenger RNA coronavirus disease 2019 vaccinations
title_fullStr Specific antibody response of 14 patients with common variable immunodeficiency to 3 BNT162b2 messenger RNA coronavirus disease 2019 vaccinations
title_full_unstemmed Specific antibody response of 14 patients with common variable immunodeficiency to 3 BNT162b2 messenger RNA coronavirus disease 2019 vaccinations
title_short Specific antibody response of 14 patients with common variable immunodeficiency to 3 BNT162b2 messenger RNA coronavirus disease 2019 vaccinations
title_sort specific antibody response of 14 patients with common variable immunodeficiency to 3 bnt162b2 messenger rna coronavirus disease 2019 vaccinations
topic Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983475/
https://www.ncbi.nlm.nih.gov/pubmed/35398265
http://dx.doi.org/10.1016/j.anai.2022.03.035
work_keys_str_mv AT abohelonizar specificantibodyresponseof14patientswithcommonvariableimmunodeficiencyto3bnt162b2messengerrnacoronavirusdisease2019vaccinations
AT muhammademad specificantibodyresponseof14patientswithcommonvariableimmunodeficiencyto3bnt162b2messengerrnacoronavirusdisease2019vaccinations
AT ghabenamarasondus specificantibodyresponseof14patientswithcommonvariableimmunodeficiencyto3bnt162b2messengerrnacoronavirusdisease2019vaccinations
AT cohenshai specificantibodyresponseof14patientswithcommonvariableimmunodeficiencyto3bnt162b2messengerrnacoronavirusdisease2019vaccinations